IRMD vs MDT
IRMD: IRADIMED CORP provides specialized MRI-compatible medical devices, specifically infusion pumps and patient monitoring systems, engineered for safe operation within magnetic resonance imaging environments. MDT: Global medical device leader deploying pacemakers, defibrillators, spinal implants, surgical robotics, and diabetes management systems to alleviate pain, restore health, and extend life across 150+ countries.
Side-by-side fundamentals
| Metric | IRMD | MDT | Edge |
|---|---|---|---|
| Price as of 2026-07-31 close | $90.86 | $85.39 | |
| Market cap as of 2026-08-03 | $1.2B | $109.3B | |
| P/E as of 2026-08-03 | 49.51 | 22.91 | MDT lower |
| PEG as of 2026-08-03 | 4.78 | 3.09 | MDT lower |
| Net margin as of 2026-08-03 | +27.4% | +13.2% | IRMD higher |
| Gross margin as of 2026-08-03 | +76.8% | +65.3% | IRMD higher |
| Operating margin as of 2026-08-03 | +32.4% | +17.8% | IRMD higher |
| ROE as of 2026-08-03 | +24.5% | +9.8% | IRMD higher |
| ROA as of 2026-08-03 | +21.3% | +5.2% | IRMD higher |
| Debt / equity as of 2026-08-03 | 0.00 | 0.57 | IRMD lower |
| Revenue growth (YoY) as of 2026-08-03 | +14.8% | +8.4% | IRMD higher |
| Revenue CAGR (3y) SEC XBRL | +16.3% | +5.2% | IRMD higher |
| Dividend yield as of 2026-08-03 | +0.9% | +3.4% | MDT higher |
| Dividend streak (yrs) SEC XBRL | 1 | 5 | MDT higher |
| Beta as of 2026-08-03 | 0.76 | 0.36 | |
| 1-year return as of 2026-07-31 close | +55.7% | -5.4% | IRMD higher |
Fundamentals: market data, as of 2026-08-03. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-31.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.